Cardiosave Hybrid and Cardiosave Rescue intra-aortic balloon pumps (IABPs) manufactured by Getinge/Datascope are being recalled due to the possibility that a coiled cable connecting the display and ...

Cite this: FDA Classifies Cardiosave IABP Recall as Class I - Medscape - Dec 16, 2021. Comments. Commenting is limited to medical professionals. To comment please Log-in. Comments ...

UPDATE: Risk of Device Failures for Getinge’s Maquet/Datascope Cardiosave Intra-Aortic Balloon Pump (IABP) – Letter to Health Care Providers.

From 1 January 2023, Getinge has initiated 12 voluntary recalls in the US for the Cardiosave IABP. The FDA classified eight as a Class I recall - the most serious type of recall.

To date, 4,454 of Getinge’s IABP devices have been recalled in the U.S. 98% clean claims, faster payments: How ModMed practices are improving RCM Recommended Live Webinar on Jun 26, 2025 11:00 ...

There is a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump devices, and the supply issue will continue into 2023, according to the FDA.The agency said it is working with Getinge to ...

The Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump IABP are electromechanical systems that inflate and deflate balloons in the aorta to provide temporary support to the left ventricle.

The warning covers Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices and the Getinge/Maquet Cardiohelp system and HLS sets ...

Getinge did not immediately respond to a Reuters request for comment. The FDA suggests providers to move away from the use of Getinge's Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP ...